| Geriatrics and Gerontology | Lifetime | 42 | NL 1 | 98.78 |
| Toxicology | Lifetime | 31 | NL 2 | 98.36 |
| Pediatrics, Perinatology and Child Health | Lifetime | 476 | NL 14 | 98.63 |
| Psychiatry and Mental health | Lifetime | 563 | NL 16 | 98.00 |
| Emergency Medical Services | Lifetime | 528 | NL 13 | 94.96 |
| Pharmacology | Lifetime | 572 | NL 9 | 93.05 |
| Family Practice | Lifetime | 168 | NL 12 | 88.42 |
| Immunology | 2021-2025 | 989 | NL 19 | 53.03 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 12 | NL 1 | 99.58 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 3 | NL 1 | 99.57 |
| Pharmaceutical studies and practices | Lifetime | 19 | NL 1 | 99.56 |
| Patient Safety and Medication Errors | Lifetime | 110 | NL 5 | 98.22 |
| Medication Adherence and Compliance | Lifetime | 158 | NL 7 | 97.43 |
| Biosimilars and Bioanalytical Methods | Lifetime | 209 | NL 24 | 96.24 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 806 | NL 32 | 96.59 |
| Schizophrenia research and treatment | Lifetime | 815 | NL 23 | 97.48 |
| Drug-Induced Adverse Reactions | Lifetime | 359 | NL 9 | 95.33 |
| Pharmaceutical Economics and Policy | Lifetime | 425 | NL 17 | 95.14 |
| Electroconvulsive Therapy Studies | Lifetime | 320 | NL 9 | 95.38 |
| Electrolyte and hormonal disorders | Lifetime | 829 | NL 23 | 94.11 |
| Pharmacy and Medical Practices | Lifetime | 209 | NL 5 | 91.80 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 910 | NL 37 | 86.10 |
| Medical Research and Practices | Lifetime | 76 | NL 6 | 79.98 |
| Healthcare Technology and Patient Monitoring | Lifetime | 873 | NL 29 | 80.52 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 561 | NL 17 | 79.02 |
| Intramuscular injections and effects | Lifetime | 973 | NL 7 | 61.36 |
| Intravenous Infusion Technology and Safety | Lifetime | 367 | NL 12 | 56.12 |
| Pharmaceutical studies and practices | 2021-2025 | 111 | NL 15 | 92.56 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 519 | NL 18 | 89.00 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 147 | NL 7 | 83.49 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 623 | NL 31 | 79.00 |
| Medication Adherence and Compliance | 2021-2025 | 628 | NL 27 | 75.52 |
| Patient Safety and Medication Errors | 2021-2025 | 793 | NL 22 | 65.69 |
| Hemophilia Treatment and Research | 2021-2025 | 768 | NL 67 | 68.47 |
| Clinical Reasoning and Diagnostic Skills | 2021-2025 | 772 | NL 43 | 63.27 |
| Chemistry and Chemical Engineering | 2021-2025 | 856 | NL 27 | 46.10 |
| Safe Handling of Antineoplastic Drugs | 2021-2025 | 316 | NL 18 | 27.77 |
